Incorporating Surrogate Endpoints into Group Sequential Trials
From MaRDI portal
Cited in
(2)
This page was built for publication: Incorporating Surrogate Endpoints into Group Sequential Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4717723)